| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.7M | — | +15.8% |
| Cost of Revenue | $5.5M | — | +344.7% |
| Gross Profit | $1.2M | — | -73.3% |
| R&D Expense | $11.0M | — | -46.2% |
| SG&A Expense | $8.1M | — | +10.0% |
| Operating Income | -$17.9M | — | +23.2% |
| Pre-tax Income | -$11.7M | — | +6.0% |
| Income Tax | $414K | — | — |
| Net Income | -$12.1M | — | +2.7% |
| EPS (Basic) | -$0.04 | — | +0.0% |
| EPS (Diluted) | -$0.04 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.9M | +58.9% | -16.3% |
| Accounts Receivable | $8.2M | +71.1% | +442.6% |
| Inventory | $7.0M | +35.0% | +4390.3% |
| Current Assets | $200.6M | -7.3% | -21.7% |
| Total Assets | $253.5M | -7.0% | -17.1% |
| Current Liabilities | $29.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.8M | — | +13.3% |
| Capital Expenditures | $330K | — | -64.0% |
| Investing Cash Flow | $39.1M | — | +178.5% |
| Financing Cash Flow | -$2.0M | — | — |
| Free Cash Flow | -$20.1M | — | +15.2% |
| +78.2% |
| Total Liabilities | $50.3M | -13.2% | +39.2% |
| Stockholders' Equity | $203.2M | -5.4% | -24.7% |